Related references
Note: Only part of the references are listed.Clinical experience with a commercially available negative oral contrast medium in PET/CT
K Hausegger et al.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN (2005)
PET for response assessment in oncology: radiotherapy and chemotherapy
WA Weber
BRITISH JOURNAL OF RADIOLOGY (2005)
Defining a radiotherapy target with positron emission tomography
QC Black et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer
J Bradley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET
D Visvikis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials
G Antoch et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
Application of oral contrast media in coregistered positron emission tomography-CT
EV Dizendorf et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
P Giraud et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Share Paper
